- entityType: Platform
  businessId: PLAT-X
  values:
      - fieldName: label
        fieldValue: Platform X
      - fieldName: hasResponsibleUnit
        fieldValue: O-HarveyDickiandMorar
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-HarveyDickiandMorar
- entityType: Platform
  businessId: P-ReportServer
  values:
      - fieldName: label
        fieldValue: Report Server
      - fieldName: description
        fieldValue: Case reporting server
      - fieldName: acronym
        fieldValue: RPTSRV
      - fieldName: hasResponsibleUnit
        fieldValue: O-ArmstrongLLC
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-ArmstrongLLC
- entityType: Platform
  businessId: P-SynopseDB
  values:
      - fieldName: label
        fieldValue: Synopsis Database
      - fieldName: hasResponsibleUnit
        fieldValue: O-PriceFayandSimonis
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-PriceFayandSimonis
- entityType: Platform
  businessId: PLAT-Y
  values:
      - fieldName: label
        fieldValue: Platform Y
      - fieldName: hasResponsibleUnit
        fieldValue: O-MurrayTowne
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-MurrayTowne
- entityType: Platform
  businessId: PLAT-Z
  values:
      - fieldName: label
        fieldValue: Platform Z
      - fieldName: hasResponsibleUnit
        fieldValue: O-JohnstonCorkery
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-JohnstonCorkery
- entityType: ExtractedResource
  businessId: PART-A
  values:
      - fieldName: label
        fieldValue: Piece 1
      - fieldName: accessPlatform
        fieldValue: PLAT-X
      - fieldName: hasResponsibleUnit
        fieldValue: O-SporerLLC
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-SporerLLC
- entityType: ExtractedResource
  businessId: PART-A
  values:
      - fieldName: description
        fieldValue: Piece 2
      - fieldName: accessPlatform
        fieldValue: PLAT-Y
      - fieldName: hasResponsibleUnit
        fieldValue: O-CruickshankInc
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-CruickshankInc
- entityType: ExtractedResource
  businessId: PART-A
  values:
      - fieldName: keyword
        fieldValue: Piece 3
      - fieldName: accessPlatform
        fieldValue: PLAT-Z
      - fieldName: hasResponsibleUnit
        fieldValue: O-AbbottWaelchi
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-AbbottWaelchi
- entityType: Source
  businessId: SOURCE-1
  values:
      - fieldName: label
        fieldValue: Cancer study
      - fieldName: label
        fieldValue: Covid vaccination study
      - fieldName: description
        fieldValue: "Many people being treated for\_cancer\_have questions about COVID-19\_vaccines\_and how COVID may affect their\_cancer\_treatment."
      - fieldName: keyword
        fieldValue: Health
      - fieldName: keyword
        fieldValue: Ministry
      - fieldName: contact
        fieldValue: U-SawyerWilliams
      - fieldName: contributor
        fieldValue: U-SawyerWilliams
      - fieldName: contributor
        fieldValue: U-QuinniBrown
      - fieldName: relatedDocumentation
        fieldValue: http://www.source.de
      - fieldName: sourceType
        fieldValue: https://mex.data4life.care/concept/source-type-7
      - fieldName: sourceType
        fieldValue: https://mex.data4life.care/concept/source-type-1
      - fieldName: fundedOrCommissionedBy
        fieldValue: O-MOH
      - fieldName: hasResponsibleUnit
        fieldValue: O-SchultzSipes
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-SchultzSipes
      - fieldName: tag
        fieldValue: ABCDEF
      - fieldName: tag
        fieldValue: WXYZ
- entityType: Organization
  businessId: O-MOH
  values:
      - fieldName: label
        fieldValue: Ministry of Health
      - fieldName: acronym
        fieldValue: MOH
      - fieldName: hasResponsibleUnit
        fieldValue: O-LynchLLC
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-LynchLLC
- entityType: Person
  businessId: U-SawyerWilliams
  values:
      - fieldName: label
        fieldValue: Sawyer Williams
      - fieldName: email
        fieldValue: s.williams@example.com
      - fieldName: hasResponsibleUnit
        fieldValue: O-HaleySchmidtandConroy
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-HaleySchmidtandConroy
- entityType: Person
  businessId: U-AliceCorona
  values:
      - fieldName: label
        fieldValue: Alice Corona
      - fieldName: email
        fieldValue: a.corona@example.com
      - fieldName: hasResponsibleUnit
        fieldValue: O-KutchGroup
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-KutchGroup
- entityType: Person
  businessId: U-QuinniBrown
  values:
      - fieldName: label
        fieldValue: Quinni Brown
      - fieldName: email
        fieldValue: QuinniBrown@example.com
      - fieldName: hasResponsibleUnit
        fieldValue: O-AnkundingFerryandRunolfsdottir
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-AnkundingFerryandRunolfsdottir
- entityType: Resource
  businessId: DOC-1
  values:
      - fieldName: label
        fieldValue: What is coronavirus? The different types of coronaviruses
      - fieldName: keyword
        fieldValue: Senior people
      - fieldName: keyword
        fieldValue: Coronavirus
      - fieldName: created
        fieldValue: "2022-07-21"
      - fieldName: description
        fieldValue: >-
            Coronaviruses are a family of viruses that cause illness in humans and
            animals. Seven different types have been found in people.
      - fieldName: resourceType
        fieldValue: Monitoring study
      - fieldName: acronym
        fieldValue: "SARS-MERS-HCoV-HKU1 "
      - fieldName: contributor
        fieldValue: U-SawyerWilliams
      - fieldName: contact
        fieldValue: U-AliceCorona
      - fieldName: contact
        fieldValue: U-QuinniBrown
      - fieldName: accessRestriction
        fieldValue: https://mex.data4life.care/concept/access-restriction-1
      - fieldName: wasExtractedFrom
        fieldValue: P-ReportServer
      - fieldName: createdInContextOf
        fieldValue: P-ReportServer
      - fieldName: createdInContextOf
        fieldValue: SOURCE-1
      - fieldName: rights
        fieldValue: Data freely available
      - fieldName: dataFileFormat
        fieldValue: CSV
      - fieldName: license
        fieldValue: MIT
      - fieldName: hasResponsibleUnit
        fieldValue: O-StromanLLC
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-StromanLLC
      - fieldName: tag
        fieldValue: ABCDEF
      - fieldName: tag
        fieldValue: WXYZ
- entityType: Resource
  businessId: DOC-2
  values:
      - fieldName: label
        fieldValue: Differences in coronavirus genomes. SARS-CoV and MERS-CoV types.
      - fieldName: keyword
        fieldValue: Clinical trial
      - fieldName: keyword
        fieldValue: Coronavirus
      - fieldName: keyword
        fieldValue: Complications
      - fieldName: description
        fieldValue: >-
            SARS-CoV is Severe acute respiratory syndrome (SARS). MERS-CoV is Middle
            East respiratory syndrome (MERS).
      - fieldName: wasExtractedFrom
        fieldValue: P-ReportServer
      - fieldName: createdInContextOf
        fieldValue: P-ReportServer
      - fieldName: rights
        fieldValue: Data freely available
      - fieldName: contact
        fieldValue: U-SawyerWilliams
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-JerdeChamplinandMohr
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-JerdeChamplinandMohr
- entityType: Resource
  businessId: DOC-2
  values:
      - fieldName: label
        fieldValue: Differences in coronavirus genomes. SARS-CoV and MERS-CoV types.
      - fieldName: keyword
        fieldValue: Clinical trial
      - fieldName: keyword
        fieldValue: Coronavirus
      - fieldName: keyword
        fieldValue: Corona virus
      - fieldName: keyword
        fieldValue: Complications
      - fieldName: description
        fieldValue: >-
            SARS-CoV is Severe acute respiratory syndrome (SARS). MERS-CoV is Middle
            East respiratory syndrome (MERS).
      - fieldName: contact
        fieldValue: U-SawyerWilliams
      - fieldName: wasExtractedFrom
        fieldValue: P-ReportServer
      - fieldName: createdInContextOf
        fieldValue: P-ReportServer
      - fieldName: rights
        fieldValue: Data freely available
      - fieldName: dataFileFormat
        fieldValue: CSV
      - fieldName: license
        fieldValue: MIT
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-WehnerChristiansenandWisoky
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-WehnerChristiansenandWisoky
- entityType: Resource
  businessId: DOC-2
  values:
      - fieldName: label
        fieldValue: Differences in coronavirus genomes. SARS-CoV and MERS-CoV types.
      - fieldName: keyword
        fieldValue: Clinical trial
      - fieldName: keyword
        fieldValue: Trial
      - fieldName: keyword
        fieldValue: Coronavirus
      - fieldName: keyword
        fieldValue: Corona virus
      - fieldName: keyword
        fieldValue: Complications
      - fieldName: description
        fieldValue: >-
            SARS-CoV is Severe acute respiratory syndrome (SARS). MERS-CoV is Middle
            East respiratory syndrome (MERS).
      - fieldName: contact
        fieldValue: U-SawyerWilliams
      - fieldName: contributor
        fieldValue: U-QuinniBrown
      - fieldName: wasExtractedFrom
        fieldValue: P-ReportServer
      - fieldName: createdInContextOf
        fieldValue: P-ReportServer
      - fieldName: rights
        fieldValue: Data freely available
      - fieldName: dataFileFormat
        fieldValue: CSV
      - fieldName: license
        fieldValue: MIT
      - fieldName: acronym
        fieldValue: corona-genome
      - fieldName: wasExtractedFrom
        fieldValue: P-SynopseDB
      - fieldName: createdInContextOf
        fieldValue: P-SynopseDB
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-WunschMullerandDonnelly
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-WunschMullerandDonnelly
- entityType: Resource
  businessId: DOC-3
  values:
      - fieldName: label
        fieldValue: >-
            Safety of COVID-19 vaccine for children with congenital heart disease.
            The most suitable coronavirus vaccines types.
      - fieldName: description
        fieldValue: >-
            New clinical considerations for coadministration of mRNA COVID-19
            vaccines and orthopoxvirus vaccines.
      - fieldName: keyword
        fieldValue: Children
      - fieldName: keyword
        fieldValue: Vaccination
      - fieldName: keyword
        fieldValue: COVID-19
      - fieldName: keyword
        fieldValue: Cardiovascular morbidity
      - fieldName: sourceType
        fieldValue: Study
      - fieldName: created
        fieldValue: "2021-05-15"
      - fieldName: hasResponsibleUnit
        fieldValue: O-WindlerSauerandKoepp
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-WindlerSauerandKoepp
- entityType: Resource
  businessId: DOC-4
  values:
      - fieldName: label
        fieldValue: Pertussis vaccine effectiveness for senior people with galactosemia.
      - fieldName: description
        fieldValue: >-
            The pertussis vaccine of new generation is created based on the same
            technology as Moderna COVID-19 vaccine.
      - fieldName: keyword
        fieldValue: Senior people
      - fieldName: keyword
        fieldValue: Vaccination
      - fieldName: keyword
        fieldValue: Rare diseases
      - fieldName: sourceType
        fieldValue: Statistical data
      - fieldName: created
        fieldValue: "2020-05-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-CorwinJones
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-CorwinJones
- entityType: Resource
  businessId: DOC-5
  values:
      - fieldName: label
        fieldValue: >-
            Cases of alpha thalassemia among men of 18 - 30 years old from
            Mediterranean countries. HbH disease.
      - fieldName: description
        fieldValue: >-
            The research has a severity scale of blood disorder that reduces the
            production of normal hemoglobin, the protein in red blood cells that
            carries oxygen to cells throughout the body.
      - fieldName: keyword
        fieldValue: Men
      - fieldName: keyword
        fieldValue: Rare diseases
      - fieldName: keyword
        fieldValue: Complications
      - fieldName: created
        fieldValue: "2022-01-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-RauLang
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-RauLang
- entityType: Resource
  businessId: DOC-6
  values:
      - fieldName: label
        fieldValue: Frequency of blood disorders cases among children in Central Asia.
      - fieldName: description
        fieldValue: >-
            The rasio of thalassemia cases among other inherited blood disorders.
            The symptoms associated with thalassemia appear within the first 2 years
            of life. Symptoms and signs include life-threatening anemia that causes
            failure to thrive (reduced growth rate and weight gain).
      - fieldName: keyword
        fieldValue: Children
      - fieldName: keyword
        fieldValue: Rare diseases
      - fieldName: keyword
        fieldValue: Complications
      - fieldName: sourceType
        fieldValue: Third party data
      - fieldName: created
        fieldValue: "2022-02-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-SchusterBlandaandFeil
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-SchusterBlandaandFeil
- entityType: Resource
  businessId: DOC-7
  values:
      - fieldName: label
        fieldValue: Covid-19 complications among men from 20 - 30 in Southern America.
      - fieldName: description
        fieldValue: >-
            COVID-19 is a highly pathogenic virus that exerts adverse effects upon
            the male genitourinary system in myriad ways. The COVID-19 infection can
            impact serum testosterone, fertility, sexual function, and mental
            health.
      - fieldName: keyword
        fieldValue: Men
      - fieldName: keyword
        fieldValue: COVID-19
      - fieldName: keyword
        fieldValue: Complications
      - fieldName: created
        fieldValue: "2021-03-11"
      - fieldName: hasResponsibleUnit
        fieldValue: O-ManteLLC
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-ManteLLC
- entityType: Resource
  businessId: DOC-8
  values:
      - fieldName: label
        fieldValue: Effectiveness of pertussis vaccination during pregnancy.
      - fieldName: description
        fieldValue: >-
            The best time for the vaccin is between 16 weeks and 32 weeks of
            pregnancy. Antenatal pertussis vaccination protects newborns before they
            are able to have their own vaccinations from 6 weeks of age. Studies
            show that it is more than 90 per cent effective in preventing pertussis
            in infants.
      - fieldName: keyword
        fieldValue: Women
      - fieldName: keyword
        fieldValue: Children
      - fieldName: keyword
        fieldValue: Pregnancy
      - fieldName: sourceType
        fieldValue: Participants data
      - fieldName: created
        fieldValue: "2022-02-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-TillmanandSons
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-TillmanandSons
- entityType: Resource
  businessId: DOC-9
  values:
      - fieldName: label
        fieldValue: Humeral diseases among women over 60.
      - fieldName: description
        fieldValue: >-
            Consisting of muscles, bones, nerves, veins, number of bonds and other
            supporting tissues, shoulder joint may cause pain for different
            conditions affecting these components. If the disorder is not treated in
            a timely manner, lifelong movement restrictions and weakness and
            increasing pain may be observed.
      - fieldName: keyword
        fieldValue: Women
      - fieldName: keyword
        fieldValue: Senior people
      - fieldName: keyword
        fieldValue: Rare diseases
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-LefflerHahnandRice
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-LefflerHahnandRice
- entityType: Resource
  businessId: DOC-10
  values:
      - fieldName: label
        fieldValue: Efficiency of humoral diseases prevention by diet and physical exercise.
      - fieldName: description
        fieldValue: >-
            Evaluation of the effects of different levels of sweet orange (Citrus
            sinensis) peel extract (SOPE) on humoral immune system responses.
            Developing disease resistance and humoral antibody production through
            high levels of vitamin C.
      - fieldName: keyword
        fieldValue: Cardiovascular morbidity
      - fieldName: keyword
        fieldValue: Complication
      - fieldName: keyword
        fieldValue: Women
      - fieldName: sourceType
        fieldValue: Statistical data
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-DonnellyBrown
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-DonnellyBrown
- entityType: Resource
  businessId: DOC-11
  values:
      - fieldName: label
        fieldValue: >-
            Analysis of health outcomes in vaccinated and unvaccinated children with
            Developmental Delay.
      - fieldName: description
        fieldValue: >-
            Using data from three medical practices in the United States with
            children born between November 2010 and June 2017, vaccinated children
            were compared to unvaccinated children during the first year of life for
            later incidence of developmental delays.
      - fieldName: keyword
        fieldValue: Children
      - fieldName: keyword
        fieldValue: Vaccination
      - fieldName: keyword
        fieldValue: Disability
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-KingVeum
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-KingVeum
- entityType: Resource
  businessId: DOC-12
  values:
      - fieldName: label
        fieldValue: >-
            Efficiency of S/AS01 malaria vaccine among children with Visual
            Impairment Including Blindness in sub-Saharan Africa and in other
            regions with moderate to high P. falciparum malaria transmission.
      - fieldName: description
        fieldValue: >-
            The research is made based on the pilot programme in Ghana, Kenya and
            Malawi that has reached more than 1 million people since 2015.
      - fieldName: keyword
        fieldValue: Children
      - fieldName: keyword
        fieldValue: Vaccination
      - fieldName: keyword
        fieldValue: Disability
      - fieldName: sourceType
        fieldValue: Third party data
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-StrackeInc
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-StrackeInc
- entityType: Resource
  businessId: DOC-13
  values:
      - fieldName: label
        fieldValue: >-
            Adult Vaccination as a Protective Factor for Dementia: A Meta-Analysis
            and Systematic Review of Population-Based Observational Studies.
      - fieldName: description
        fieldValue: >-
            Common vaccinations may have impacts on dementia risk, but current
            evidence is inconsistent. We therefore investigated the association
            between vaccinations and dementia risk by systematic review and
            meta-analysis approach.
      - fieldName: keyword
        fieldValue: Senior people
      - fieldName: keyword
        fieldValue: Vaccination
      - fieldName: keyword
        fieldValue: Mental health
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-MurrayTowne
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-MurrayTowne
- entityType: Resource
  businessId: DOC-14
  values:
      - fieldName: label
        fieldValue: Efficiency of pneumonia vaccine for adults age 65 and older.
      - fieldName: description
        fieldValue: >-
            Pneumonia vaccines are particularly important for older adults. Risks to
            pneumonia is higher for this age group since it can be more difficult to
            fight off infections as your immune system naturally weakens as you get
            older.
      - fieldName: keyword
        fieldValue: Senior people
      - fieldName: keyword
        fieldValue: Vaccination
      - fieldName: sourceType
        fieldValue: Participants data
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-LegrosBrakusandBrekke
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-LegrosBrakusandBrekke
- entityType: Resource
  businessId: DOC-15
  values:
      - fieldName: label
        fieldValue: COVID-19 vaccination impacts on menstrual cycle.
      - fieldName: description
        fieldValue: >-
            To see how vaccination impacted periods, the researchers analyse data
            from three consecutive cycles before vaccination, and from three
            afterwards – including the cycle or cycles in which vaccination took
            place. For unvaccinated individuals, data are collected for six
            consecutive cycles.
      - fieldName: keyword
        fieldValue: COVID-19
      - fieldName: keyword
        fieldValue: Women
      - fieldName: keyword
        fieldValue: Vaccination
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-MacGyverFraneyandWolf
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-MacGyverFraneyandWolf
- entityType: Resource
  businessId: DOC-16
  values:
      - fieldName: label
        fieldValue: Vaccine development for rheumatoid arthritis.
      - fieldName: description
        fieldValue: >-
            A protein-based vaccine has proven a promising option to prevent
            rheumatoid arthritis, improving bone quality in animal models.
      - fieldName: keyword
        fieldValue: Vaccination
      - fieldName: keyword
        fieldValue: Senior people
      - fieldName: keyword
        fieldValue: Clinical trial
      - fieldName: sourceType
        fieldValue: Statistical data
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-BlockOsinskiandCasper
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-BlockOsinskiandCasper
- entityType: Resource
  businessId: DOC-17
  values:
      - fieldName: label
        fieldValue: >-
            Efficacy of vaccination with the HIV immunogen eOD-GT8 60mer, delivered
            via Moderna’s mRNA platform.
      - fieldName: description
        fieldValue: >-
            An mRNA vaccine works by delivering a piece of genetic material that
            instructs the body to make a protein fragment of a target pathogen (such
            as a virus), which the immune system recognizes and remembers, so it can
            mount a substantial response if later exposed to that pathogen.
      - fieldName: keyword
        fieldValue: Vaccination
      - fieldName: keyword
        fieldValue: Clinical trial
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-KirlinPfannerstillandWaters
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-KirlinPfannerstillandWaters
- entityType: Resource
  businessId: DOC-18
  values:
      - fieldName: label
        fieldValue: >-
            Efficiency of pertussis-containing vaccines for children at 2, 4, 6 and
            18 months.
      - fieldName: description
        fieldValue: >-
            Pertussis-containing vaccines are only available in Australia as
            combination vaccines that include other antigens such as diphtheria and
            tetanus.
      - fieldName: keyword
        fieldValue: Women
      - fieldName: keyword
        fieldValue: Children
      - fieldName: keyword
        fieldValue: Pregnancy
      - fieldName: sourceType
        fieldValue: Third party data
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: hasResponsibleUnit
        fieldValue: O-TillmanandSons
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-TillmanandSons
- entityType: Resource
  businessId: DOC-19
  values:
      - fieldName: label
        fieldValue: >-
            Clinical trial of cancer vaccination for advanced esophageal cancer with
            three peptides derived from novel cancer-testis antigens.
      - fieldName: description
        fieldValue: >-
            ESCC patients were enrolled to evaluate OS, PFS, immunological response
            employing ELISPOT and pentamer assays.
      - fieldName: keyword
        fieldValue: Vaccination
      - fieldName: keyword
        fieldValue: Clinical trial
      - fieldName: keyword
        fieldValue: Cancer
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: acronym
        fieldValue: CANC-OES
      - fieldName: contributor
        fieldValue: U-SawyerWilliams
      - fieldName: contact
        fieldValue: U-AliceCorona
      - fieldName: contact
        fieldValue: U-QuinniBrown
      - fieldName: accessRestriction
        fieldValue: https://mex.data4life.care/concept/access-restriction-2
      - fieldName: wasExtractedFrom
        fieldValue: P-ReportServer
      - fieldName: createdInContextOf
        fieldValue: P-ReportServer
      - fieldName: createdInContextOf
        fieldValue: P-SynopseDB
      - fieldName: rights
        fieldValue: Data freely available
      - fieldName: dataFileFormat
        fieldValue: CSV
      - fieldName: dataFileFormat
        fieldValue: XLS
      - fieldName: license
        fieldValue: MIT
      - fieldName: relatedExternalIdentifier
        fieldValue: COVID-CANC-555
      - fieldName: accessLocation
        fieldValue: https://covid-study.com/vaccination
      - fieldName: hasResponsibleUnit
        fieldValue: O-LueilwitzWilkinsonandAufderhar
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-LueilwitzWilkinsonandAufderhar
      - fieldName: tag
        fieldValue: ABCDEF
      - fieldName: tag
        fieldValue: D004263
- entityType: Resource
  businessId: DOC-20
  values:
      - fieldName: label
        fieldValue: COVID-19 Vaccines and People with Cancer.
      - fieldName: description
        fieldValue: >-
            Many people being treated for cancer have questions about COVID-19
            vaccines and how COVID may affect their cancer treatment.
      - fieldName: keyword
        fieldValue: Vaccination
      - fieldName: resourceType
        fieldValue: Participants dataa
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: contributor
        fieldValue: U-SawyerWilliams
      - fieldName: contact
        fieldValue: U-AliceCorona
      - fieldName: contact
        fieldValue: U-QuinniBrown
      - fieldName: accessRestriction
        fieldValue: https://mex.data4life.care/concept/access-restriction-1
      - fieldName: wasExtractedFrom
        fieldValue: P-ReportServer
      - fieldName: createdInContextOf
        fieldValue: P-ReportServer
      - fieldName: createdInContextOf
        fieldValue: SOURCE-1
      - fieldName: dataFileFormat
        fieldValue: CSV
      - fieldName: license
        fieldValue: BSD3
      - fieldName: relatedExternalIdentifier
        fieldValue: COVID-CANC-123
      - fieldName: accessLocation
        fieldValue: https://covid-study.com/vaccination
      - fieldName: hasResponsibleUnit
        fieldValue: O-GoldnerKlingandWisoky
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-GoldnerKlingandWisoky
- entityType: Resource
  businessId: DOC-20
  values:
      - fieldName: label
        fieldValue: COVID-19 Vaccines and People with Cancer.
      - fieldName: description
        fieldValue: >-
            Many people being treated for cancer have questions about COVID-19
            vaccines and how COVID may affect their cancer treatment.
      - fieldName: keyword
        fieldValue: Vaccination
      - fieldName: keyword
        fieldValue: Clinical trial
      - fieldName: keyword
        fieldValue: COVID-19
      - fieldName: resourceType
        fieldValue: Participants dataa
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: acronym
        fieldValue: "SARS-MERS-HCoV-HKU1 "
      - fieldName: contributor
        fieldValue: U-SawyerWilliams
      - fieldName: contact
        fieldValue: U-AliceCorona
      - fieldName: contact
        fieldValue: U-QuinniBrown
      - fieldName: accessRestriction
        fieldValue: https://mex.data4life.care/concept/access-restriction-1
      - fieldName: wasExtractedFrom
        fieldValue: P-ReportServer
      - fieldName: createdInContextOf
        fieldValue: P-ReportServer
      - fieldName: createdInContextOf
        fieldValue: SOURCE-1
      - fieldName: rights
        fieldValue: Data freely available
      - fieldName: dataFileFormat
        fieldValue: CSV
      - fieldName: license
        fieldValue: MIT
      - fieldName: relatedExternalIdentifier
        fieldValue: COVID-CANC-123
      - fieldName: accessLocation
        fieldValue: https://covid-study.com/vaccination
      - fieldName: hasResponsibleUnit
        fieldValue: O-SchultzInc
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-SchultzInc
- entityType: Resource
  businessId: DOC-20
  values:
      - fieldName: label
        fieldValue: COVID-19 Vaccines and People with Cancer.
      - fieldName: description
        fieldValue: >-
            Many people being treated for cancer have questions about COVID-19
            vaccines and how COVID may affect their cancer treatment.
      - fieldName: keyword
        fieldValue: Vaccination
      - fieldName: keyword
        fieldValue: Clinical trial
      - fieldName: keyword
        fieldValue: COVID-19
      - fieldName: resourceType
        fieldValue: Participants data
      - fieldName: created
        fieldValue: "2022-05-01"
      - fieldName: acronym
        fieldValue: "SARS-MERS-HCoV-HKU1 "
      - fieldName: contributor
        fieldValue: U-SawyerWilliams
      - fieldName: contact
        fieldValue: U-AliceCorona
      - fieldName: contact
        fieldValue: U-QuinniBrown
      - fieldName: accessRestriction
        fieldValue: https://mex.data4life.care/concept/access-restriction-1
      - fieldName: wasExtractedFrom
        fieldValue: P-ReportServer
      - fieldName: createdInContextOf
        fieldValue: P-ReportServer
      - fieldName: createdInContextOf
        fieldValue: SOURCE-1
      - fieldName: rights
        fieldValue: Data freely available
      - fieldName: dataFileFormat
        fieldValue: CSV
      - fieldName: license
        fieldValue: MIT
      - fieldName: relatedExternalIdentifier
        fieldValue: COVID-CANC-123
      - fieldName: relatedExternalIdentifier
        fieldValue: COVID-CANC-666
      - fieldName: accessLocation
        fieldValue: https://covid-study.com/vaccination
      - fieldName: hasResponsibleUnit
        fieldValue: O-MurrayTowne
      - fieldName: hasResponsibleUnitCode
        fieldValue: O-MurrayTowne
